Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes …

C Churuangsuk, J Hall, A Reynolds, SJ Griffin… - Diabetologia, 2022 - Springer
Aims/hypothesis Weight reduction is fundamental for type 2 diabetes management and
remission, but uncertainty exists over which diet type is best to achieve and maintain weight …

[HTML][HTML] IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy

S Shkunnikova, A Mijakovac, L Sironic, M Hanic… - Biotechnology …, 2023 - Elsevier
Immunoglobulin (IgG) glycosylation is a complex enzymatically controlled process, essential
for the structure and function of IgG. IgG glycome is relatively stable in the state of …

Evidence-based European recommendations for the dietary management of diabetes

Diabetologia, 2023 - Springer
Diabetes management relies on effective evidence-based advice that informs and
empowers individuals to manage their health. Alongside other cornerstones of diabetes …

Common and divergent molecular mechanisms of fasting and ketogenic diets

A Paoli, GM Tinsley, MP Mattson, I De Vivo… - Trends in Endocrinology …, 2024 - cell.com
Intermittent short-term fasting (ISTF) and ketogenic diets (KDs) exert overlapping but not
identical effects on cell metabolism, function, and resilience. Whereas health benefits of KD …

[HTML][HTML] Current evidence concerning effects of ketogenic diet and intermittent fasting in patients with nonalcoholic fatty liver

P Sripongpun, C Churuangsuk… - Journal of clinical and …, 2022 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is emerging globally, while no therapeutic
medication has been approved as an effective treatment to date, lifestyle intervention …

[HTML][HTML] Sodium-glucose co-transporter 2 inhibitor-associated euglycemic diabetic ketoacidosis after bariatric surgery: a case and literature review

V Kapila, J Topf - Cureus, 2021 - ncbi.nlm.nih.gov
Abstract Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce cardiovascular, kidney,
and overall mortality. SGLT2i are also associated with a rare adverse event, euglycemic …

Sodium-glucose co-transporter-2 inhibitors induced diabetic ketoacidosis in patients undergoing bariatric surgery: a systematic review of case reports and case series

N Gokhare Viswanath, M Sharma, N Bandlamudi, I Idris… - Obesity Surgery, 2023 - Springer
Abstract Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are glucose-lowering agents
being increasingly used for cardio-renal protection in patients with or without type 2 diabetes …

The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?

M Koutentakis, J Kuciński, D Świeczkowski… - Journal of …, 2023 - mdpi.com
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors, also called gliflozins or flozins, are a
class of drugs that have been increasingly used in the management of type 2 diabetes …

Beta-hydroxybutyrate promotes basal insulin secretion while decreasing glucagon secretion in mouse and human islets

R Banerjee, Y Zhu, GP Brownrigg, R Moravcova… - …, 2024 - academic.oup.com
Dietary carbohydrates raise blood glucose levels, and limiting carbohydrate intake improves
glycemia in patients with type 2 diabetes. Low carbohydrate intake (< 25 g) allows the body …

Geometry design for a fully insertable glucose biosensor with multimodal optical readout

J Fine, GL Coté, MJ McShane - Journal of Biomedical Optics, 2022 - spiedigitallibrary.org
Significance Insertable optical continuous glucose monitors (CGMs) with wearable readers
are a strong option for monitoring individuals with diabetes. However, a fully insertable CGM …